What is the best management approach for a patient with Glenohumeral (shoulder joint) arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Glenohumeral Arthritis

First-Line Treatment: Conservative Management

All patients with glenohumeral arthritis should begin with exercise-based physical therapy, patient education, and weight loss (if appropriate) as the foundation of treatment. 1, 2

Exercise Therapy

  • Exercise is the cornerstone intervention with goals of decreasing pain, increasing range of motion, and protecting the glenohumeral joint through rotator cuff strengthening 2, 3
  • No specific exercise prescription (duration, intensity, frequency) has proven superior, so recommendations should be based on patient preference and access, including walking, cycling, resistance training, or neuromuscular training 2
  • Physical therapy is most effective for motion-related pain rather than rest pain 3
  • Scapular stabilization exercises should be included, as abnormal scapular motion develops as adaptation to restricted glenohumeral motion 3

Pharmacologic Management (Second-Line)

NSAIDs (oral or topical) should be used as first-line pharmacologic therapy after exercise therapy. 1

Injectable Corticosteroids

  • Evidence is insufficient to recommend for or against corticosteroid injections (Grade I recommendation), though they are widely used in clinical practice 1, 2, 4
  • Use cautiously in athletes due to potential cartilage damage 2
  • May provide temporary relief but should not be relied upon as sole treatment 2

Viscosupplementation (Hyaluronic Acid)

  • Represents a treatment option with Grade C recommendation 2, 4
  • Typically administered as three weekly injections 2
  • Provides improvements in pain and function scores at 1,3, and 6 months 2
  • Evidence is mixed, particularly in athletes 3

Oral Supplements

  • Vitamin C and vitamin D supplementation may help slow cartilage degeneration 3
  • Glucosamine and chondroitin have insufficient evidence for glenohumeral OA specifically (unable to recommend for or against) 1

Avoid These Medications

  • Do NOT use bisphosphonates, colchicine, hydroxychloroquine, methotrexate, or diacerein for glenohumeral OA 1

Surgical Management (Third-Line)

When to Consider Surgery

  • Surgery is indicated when conservative management fails and symptoms remain debilitating 5
  • Arthroscopic treatment may be considered as a bridging procedure in young or active patients (<50 years) with early-stage OA who are not candidates for arthroplasty 2, 6
  • Arthroscopic management has 60% survival rate at 10-year follow-up but works best in patients with >2mm joint space remaining 6

Total Shoulder Arthroplasty (TSA) - Preferred Surgical Option

Total shoulder arthroplasty is superior to hemiarthroplasty for glenohumeral osteoarthritis (Grade B recommendation, Level II evidence). 2, 4, 5

  • TSA provides statistically superior pain relief and global health assessment scores compared to hemiarthroplasty 2, 4, 5
  • 14% of hemiarthroplasty patients require revision to TSA due to progressive glenoid arthrosis and pain 2, 4, 5
  • All-polyethylene glenoid components have lower revision rates (1.7%) compared to metal-backed designs (6.8%) 5

Critical Contraindications and Special Considerations

DO NOT perform traditional TSA in patients with irreparable rotator cuff tears (consensus recommendation). 2, 4, 5

  • Reverse total shoulder arthroplasty should be used instead when irreparable rotator cuff tears are present 2, 4, 5
  • Avoid arthroplasty in patients under 50 years when possible due to increased risk of prosthetic loosening and decreased survivorship 2, 4, 5
  • Pre-operative imaging must evaluate glenoid morphology, bone loss, retroversion, bone quality, and rotator cuff integrity 2, 4, 5

Surgeon Selection

  • Refer to surgeons performing at least 2 shoulder arthroplasties per year to reduce immediate postoperative complications and length of stay (Grade C recommendation) 2, 4, 5

Expected Complications

  • Complications occur in up to 39.8% of cases with revision rates up to 11% 2, 4, 5
  • Most common TSA complications: glenoid loosening (14.3%) 2, 5
  • Most common hemiarthroplasty complications: glenoid erosion (20.6%) 2, 5

Perioperative Management

All shoulder arthroplasty patients must receive mechanical and/or chemical venous thromboembolism prophylaxis (consensus recommendation). 2, 4, 5

Post-Operative Physical Therapy

  • Physical therapy following shoulder arthroplasty is commonly practiced, but no high-quality studies demonstrate whether it improves outcomes (Grade I recommendation) 1, 4
  • Despite lack of evidence, formal physical therapy remains a consistent recommendation in clinical practice 1

Common Pitfalls to Avoid

  • Do not extrapolate all treatment recommendations from hip and knee OA literature, as shoulder-specific evidence is limited 2, 4
  • Do not rely solely on corticosteroid injections without concurrent exercise therapy 2
  • Do not perform traditional TSA in patients with irreparable rotator cuff tears 2, 4, 5
  • Do not skip pre-operative imaging assessment of rotator cuff integrity and glenoid morphology 2, 4, 5
  • Do not refer to low-volume surgeons (<2 cases per year) 2, 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Shoulder Osteoarthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Non-operative management of shoulder osteoarthritis: Current concepts.

Journal of ISAKOS : joint disorders & orthopaedic sports medicine, 2023

Guideline

Treatment of Glenohumeral Joint Space Narrowing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Severe Glenohumeral Joint Narrowing with Erosion and Hypertrophic Spurring: Orthopedic Referral Required

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Editorial Commentary: Arthroscopic Treatment of Glenohumeral Arthritis-Avoiding Heavy Metal!

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.